| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | dynein complex | 1.45e-04 | 54 | 103 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.47e-04 | 25 | 103 | 3 | GO:0005858 | |
| Domain | EamA_dom | 4.89e-05 | 14 | 98 | 3 | IPR000620 | |
| Domain | EamA | 4.89e-05 | 14 | 98 | 3 | PF00892 | |
| Domain | ATPase_dyneun-rel_AAA | 4.89e-05 | 14 | 98 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.89e-05 | 14 | 98 | 3 | PF07728 | |
| Domain | DUF3669_Znf | 4.03e-04 | 6 | 98 | 2 | IPR022137 | |
| Domain | DUF3669 | 4.03e-04 | 6 | 98 | 2 | PF12417 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 9056918 | ||
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 1.04e-07 | 4 | 104 | 3 | 17101974 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37249813 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 8.86e-06 | 2 | 104 | 2 | 31400758 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37450367 | ||
| Pubmed | DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia. | 2.65e-05 | 3 | 104 | 2 | 26918822 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 19306865 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 19254709 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 37277019 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 27482003 | ||
| Pubmed | 1.33e-04 | 33 | 104 | 3 | 18662545 | ||
| Pubmed | Global control of motor neuron topography mediated by the repressive actions of a single hox gene. | 1.73e-04 | 36 | 104 | 3 | 20826310 | |
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 14766174 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 9853118 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 9303529 | ||
| Pubmed | PRC1 sustains the integrity of neural fate in the absence of PRC2 function. | 2.03e-04 | 38 | 104 | 3 | 34994686 | |
| Pubmed | 2.23e-04 | 285 | 104 | 6 | 32838362 | ||
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 26292834 | ||
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 17903303 | ||
| Pubmed | Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. | 2.45e-04 | 8 | 104 | 2 | 28169986 | |
| Pubmed | 2.66e-04 | 103 | 104 | 4 | 10574462 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 21854845 | ||
| Pubmed | 3.19e-04 | 430 | 104 | 7 | 32581705 | ||
| Pubmed | 3.83e-04 | 47 | 104 | 3 | 8812413 | ||
| Pubmed | 3.92e-04 | 10 | 104 | 2 | 33744254 | ||
| Pubmed | Development of the intrinsic innervation of the small bowel mucosa and villi. | 4.79e-04 | 11 | 104 | 2 | 31682159 | |
| Pubmed | 4.79e-04 | 11 | 104 | 2 | 24362892 | ||
| Pubmed | 5.01e-04 | 332 | 104 | 6 | 37433992 | ||
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 15497153 | ||
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 14557543 | ||
| Pubmed | 6.76e-04 | 13 | 104 | 2 | 35942101 | ||
| Pubmed | 7.87e-04 | 14 | 104 | 2 | 9373155 | ||
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 8.64e-04 | 62 | 104 | 3 | 17975119 | |
| Pubmed | 9.05e-04 | 63 | 104 | 3 | 11572484 | ||
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 9.05e-04 | 63 | 104 | 3 | 19023099 | |
| Pubmed | 9.62e-04 | 674 | 104 | 8 | 37196079 | ||
| Pubmed | 1.08e-03 | 529 | 104 | 7 | 14621295 | ||
| Pubmed | Hoxc10 and Hoxd10 regulate mouse columnar, divisional and motor pool identity of lumbar motoneurons. | 1.17e-03 | 17 | 104 | 2 | 18065432 | |
| Pubmed | 1.31e-03 | 18 | 104 | 2 | 19423521 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.38e-03 | 552 | 104 | 7 | 10737800 | |
| Pubmed | 1.46e-03 | 19 | 104 | 2 | 34188037 | ||
| Pubmed | 1.62e-03 | 20 | 104 | 2 | 19079260 | ||
| Pubmed | 1.62e-03 | 20 | 104 | 2 | 35177643 | ||
| Pubmed | Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development. | 1.62e-03 | 20 | 104 | 2 | 21606200 | |
| Pubmed | Runx1 expression defines a subpopulation of displaced amacrine cells in the developing mouse retina. | 1.62e-03 | 20 | 104 | 2 | 16026391 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 CTC1 KAT6A MYOM3 APBB3 TBC1D17 C2CD3 MDN1 ZNF398 ZER1 | 1.77e-03 | 1105 | 104 | 10 | 35748872 |
| Pubmed | 2.15e-03 | 85 | 104 | 3 | 23055939 | ||
| Pubmed | SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. | 2.15e-03 | 23 | 104 | 2 | 36414671 | |
| Pubmed | 2.29e-03 | 604 | 104 | 7 | 38803224 | ||
| Pubmed | 2.45e-03 | 89 | 104 | 3 | 24529757 | ||
| Pubmed | 2.54e-03 | 25 | 104 | 2 | 29379870 | ||
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 2.86e-03 | 94 | 104 | 3 | 37468549 | |
| Pubmed | 2.96e-03 | 27 | 104 | 2 | 20080794 | ||
| Cytoband | 12p11 | 1.81e-04 | 9 | 104 | 2 | 12p11 | |
| GeneFamily | Solute carriers | SLC9A9 SLC5A9 SLC35G4 SLC13A4 SLC18A3 SLC35G3 SLC35G5 SLC49A3 | 8.22e-05 | 395 | 65 | 8 | 752 |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 6.85e-04 | 11 | 65 | 2 | 559 | |
| GeneFamily | Dyneins, axonemal | 1.67e-03 | 17 | 65 | 2 | 536 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_UP | 1.49e-05 | 201 | 103 | 7 | M10664 | |
| Coexpression | KRAS.300_UP.V1_DN | 1.95e-05 | 140 | 103 | 6 | M2874 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 169 | 103 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.01e-06 | 194 | 103 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 197 | 103 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 6.75e-06 | 198 | 103 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 3.86e-05 | 163 | 103 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.33e-05 | 167 | 103 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-05 | 171 | 103 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-05 | 180 | 103 | 5 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-05 | 184 | 103 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-05 | 184 | 103 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.04e-05 | 185 | 103 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.22e-05 | 186 | 103 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.40e-05 | 187 | 103 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 7.59e-05 | 188 | 103 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.98e-05 | 190 | 103 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.98e-05 | 190 | 103 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Control / Condition, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | 76c2fbc62855a65600cd6b8dd1e2d2c3d7415921 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.18e-05 | 191 | 103 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 103 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.38e-05 | 192 | 103 | 5 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.38e-05 | 192 | 103 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.59e-05 | 193 | 103 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.59e-05 | 193 | 103 | 5 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 193 | 103 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.59e-05 | 193 | 103 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.59e-05 | 193 | 103 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.59e-05 | 193 | 103 | 5 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 8.80e-05 | 194 | 103 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.80e-05 | 194 | 103 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.80e-05 | 194 | 103 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.80e-05 | 194 | 103 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.80e-05 | 194 | 103 | 5 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-05 | 195 | 103 | 5 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.01e-05 | 195 | 103 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.01e-05 | 195 | 103 | 5 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.01e-05 | 195 | 103 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.01e-05 | 195 | 103 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-05 | 196 | 103 | 5 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.23e-05 | 196 | 103 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-05 | 196 | 103 | 5 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.23e-05 | 196 | 103 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-05 | 196 | 103 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-05 | 197 | 103 | 5 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.46e-05 | 197 | 103 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.46e-05 | 197 | 103 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.46e-05 | 197 | 103 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.46e-05 | 197 | 103 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.46e-05 | 197 | 103 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.46e-05 | 197 | 103 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 103 | 5 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | 2b724d2a36843801984d46a969d33149b76c9771 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.69e-05 | 198 | 103 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.69e-05 | 198 | 103 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-05 | 199 | 103 | 5 | ce8dbfd969b3b9c08e1c57c2bfd899818e878731 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 103 | 5 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 200 | 103 | 5 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 200 | 103 | 5 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype | 1.02e-04 | 200 | 103 | 5 | 4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 103 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 103 | 5 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | 3523ec986e8c9e176e08836c974b1de8b56d8b16 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 200 | 103 | 5 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | c210b98a75ab5d899d7278bc9b577f76a0b3970c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 103 | 5 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 200 | 103 | 5 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 200 | 103 | 5 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 128 | 103 | 4 | 9a800beca5cfc7b41f5eed500d45064cfa61c5de | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 128 | 103 | 4 | 920ede29f3de68e4d08644a1da53849e0c0973fb | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-04 | 139 | 103 | 4 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 139 | 103 | 4 | 96e6fed23e7a69f678f85e8e2fe77a7491586b4b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-04 | 57 | 103 | 3 | 5ae53d915bee8a5fc7936d2a46517da1b6abbf79 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-04 | 57 | 103 | 3 | e61b10212685e5217550db0812141a1f3f6567c8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-04 | 57 | 103 | 3 | f5edb5e8eddc51e0b8040e88baa5d8971871f9ea | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 3.86e-04 | 148 | 103 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.16e-04 | 151 | 103 | 4 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 154 | 103 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 155 | 103 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 157 | 103 | 4 | 3c6be6995c00c4cadbd209c66bf9a87c8c238652 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 157 | 103 | 4 | 662d5026e0e4249029fc6f3abc771d775d7bc3bb | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.82e-04 | 157 | 103 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| Disease | intercellular adhesion molecule 5 measurement | 9.32e-06 | 13 | 96 | 3 | EFO_0008164 | |
| Disease | chronic mucocutaneous candidiasis (is_implicated_in) | 1.04e-04 | 5 | 96 | 2 | DOID:2058 (is_implicated_in) | |
| Disease | Candidiasis, Chronic Mucocutaneous | 1.56e-04 | 6 | 96 | 2 | C0006845 | |
| Disease | Cerebellar Diseases | 2.18e-04 | 7 | 96 | 2 | C0007760 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 6.77e-04 | 12 | 96 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | uric acid measurement | 8.58e-04 | 610 | 96 | 8 | EFO_0004761 | |
| Disease | language measurement | 9.78e-04 | 134 | 96 | 4 | EFO_0007797 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.07e-03 | 15 | 96 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | opioid dependence | 1.08e-03 | 237 | 96 | 5 | EFO_0005611 | |
| Disease | sphingomyelin 18:0 measurement | 1.22e-03 | 16 | 96 | 2 | EFO_0010393 | |
| Disease | melanoma | 1.32e-03 | 248 | 96 | 5 | C0025202 | |
| Disease | Malaria | 1.92e-03 | 20 | 96 | 2 | C0024530 | |
| Disease | Nerve Degeneration | 2.54e-03 | 83 | 96 | 3 | C0027746 | |
| Disease | ICAM-1 measurement | 2.76e-03 | 24 | 96 | 2 | EFO_0004520 | |
| Disease | malaria (is_implicated_in) | 2.76e-03 | 24 | 96 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | Brain Diseases | 2.99e-03 | 25 | 96 | 2 | C0006111 | |
| Disease | breast cancer (is_marker_for) | 3.17e-03 | 185 | 96 | 4 | DOID:1612 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTTPPCSEIVEWIVF | 256 | P23470 | |
| EWVPTPCALSILALL | 76 | Q8N616 | |
| CLLELPPSQILDTWS | 501 | Q14146 | |
| RQWLSSPELLQSVCE | 551 | Q86VI1 | |
| LLQWTCPEDSLPLAV | 46 | Q96N23 | |
| QNWLVEVPIVSPICR | 176 | Q9UKH3 | |
| RTCLPDLTWSGIQPE | 3391 | Q7Z407 | |
| PEPWLLVALRIQCDA | 101 | A6NEN9 | |
| FLWTLCTSPSVLRPI | 1141 | Q2NKJ3 | |
| CEVWNPVSVSRSEPI | 201 | Q2WEN9 | |
| LPKVLERWSTCPRTI | 366 | Q8WXI3 | |
| SNPEEPWRNSLRCIS | 221 | Q5XX13 | |
| LPSSLEWILNICSPF | 351 | Q8N139 | |
| EPRIIPQTSLCLLWN | 5846 | Q8WXG9 | |
| ELRVWAVLPSSPEAC | 156 | Q5T440 | |
| LPARQILPTAEETWL | 391 | P48052 | |
| RIPVPNLVDSWASLL | 1911 | Q5JWR5 | |
| PTPSDCQLLREQWIR | 96 | O75689 | |
| LCTELLWPSSPASLQ | 86 | Q9ULJ7 | |
| LSTPPCSETVTWILI | 241 | O75493 | |
| IQRWSPIASTLPELV | 316 | Q13561 | |
| WSLTDEVICRRVQLP | 1506 | Q9ULI1 | |
| VPRLPRSTTAIVWSC | 6 | Q7Z2G1 | |
| NITEPLCSLDINWPR | 941 | Q15334 | |
| TSWVPLVSRICPNDV | 131 | Q8IZ07 | |
| SNPEEPWRNSLRCIS | 221 | O95170 | |
| LIPSPELQEWRVACI | 671 | O14936 | |
| TPVTPQELRDLWSLL | 2981 | Q9NU22 | |
| PWEVLATQPFCLRES | 746 | Q14676 | |
| SCALWVSQPPEIRTL | 16 | O14931 | |
| CPRQWPELIPTLIES | 121 | Q9UI26 | |
| WLVTLENSPCITPEL | 671 | Q9UI26 | |
| DCTQTPWLPVLVVSL | 6 | Q9UNE0 | |
| TLTCRAEAWPPAQIS | 766 | Q9UMF0 | |
| VSDPDALRPLLSLQW | 646 | O94953 | |
| PWIEETRALIAQLPS | 1921 | O94854 | |
| ALWASIPCPRSELRL | 21 | O15527 | |
| TAWRRALPLSCPLET | 911 | Q96FC9 | |
| CLQELREPPDWLVTT | 186 | A6NMN3 | |
| ISNWTDELRLPPCTI | 1081 | P29475 | |
| ASAVLCALVWTPTLP | 121 | Q86SM5 | |
| LCWRSESLPRAPLNV | 91 | O00634 | |
| SLTRWLPNLTDVVVP | 241 | Q86VR8 | |
| PECLRWTPVIVSNSV | 771 | Q92794 | |
| DCIWILAAPPETRIQ | 2246 | O60494 | |
| RPCPIILWDASLSSA | 306 | Q6UWH4 | |
| EEPLWQCPVRLVTFI | 351 | O95704 | |
| WIQDCQSLEIPIDPS | 3021 | Q9C0G6 | |
| PWPQQACTRVTELTE | 866 | Q9BX69 | |
| TVTISTPRLWLPIHC | 1406 | Q4AC94 | |
| TVIWDNETPICDRIP | 151 | P17927 | |
| PIPDSAIVNTRRCWS | 676 | Q9H8Y5 | |
| IADCRLWPVEITRVP | 301 | Q5T0N1 | |
| PPRSSNDAVLLWIAI | 51 | Q9NPU4 | |
| PVTEVLNQVCPSTWR | 391 | O15063 | |
| WTDPNRSCRIEQPVT | 81 | P28358 | |
| RLSREVIAWLCPSSP | 26 | Q6IMN6 | |
| PSSQLLRPWTLCPEL | 431 | P19235 | |
| WSVRLLTRADAECPP | 216 | Q8N1N5 | |
| ETWPQLLRELCSTPV | 506 | Q5T6L9 | |
| LSSLPPWAVTLLACI | 496 | Q9UKG4 | |
| RPATDLLLAWNPICL | 31 | Q9Y2H2 | |
| AEVSQWTRLCELTIP | 141 | Q8NEC7 | |
| WEESDPRTPLICLLS | 4036 | Q8TE73 | |
| CLCIQVWPLEPDSVR | 341 | Q8NAC3 | |
| WTFSPQVTRILPCLL | 436 | O15259 | |
| PEPRICFLEAIWSNI | 516 | Q86XP0 | |
| LQTPVLPSDLLSWSC | 241 | Q96KT7 | |
| CLIWVLRFPLPSIET | 2136 | O75691 | |
| LQAPVLPSDLLSWSC | 241 | Q8N808 | |
| CIRWVTPPTQIVCLP | 251 | Q9UQF0 | |
| CNIPLAFLEPTIATW | 301 | Q16572 | |
| TLPEWCGPISRLLTS | 551 | Q8IVB4 | |
| TVWAPRLPLQIEISD | 511 | Q14DG7 | |
| RWPQLCSTQSDIVPI | 236 | Q5HYW2 | |
| PLLDSFTRLCLPEAW | 446 | Q9NVX7 | |
| ICVSLPWGDPSQITR | 191 | Q8WVD3 | |
| RVSETCIVPAWLPSL | 371 | Q2M3G4 | |
| CTTPIPEEQLTRLTW | 551 | Q2M3M2 | |
| IVNLICSSRPWPDRQ | 876 | O60518 | |
| LPTVWVRLLCPVPSE | 316 | Q7Z7M1 | |
| VSPLESWLTARCFLP | 71 | Q9NWT8 | |
| FIQWLLSRPTILPEE | 271 | Q8NEL0 | |
| PRRWPVQVLSILCSL | 101 | Q8N6S5 | |
| SCAASPPWRLIAVIL | 36 | Q9BXN2 | |
| PREPGLCTWQSLRSQ | 191 | P01033 | |
| VCLLSTICLWESVPP | 206 | Q6UXD7 | |
| LQSPVLPSDLLSWSC | 241 | P0C7Q5 | |
| EPDWAVISTVRPQLC | 86 | Q9HA65 | |
| IPSLTDCLQWFTRPE | 546 | Q70EK9 | |
| IDWVPVESLLRPLNS | 186 | Q7Z7L7 | |
| TPLNLAVNWRCEPSS | 686 | Q9BQI5 | |
| QRPAFPEWLTVLLLC | 1016 | O94759 | |
| EWDSECLTSLQPLPL | 11 | Q8TD17 | |
| PTRVCTNPVATLLEW | 746 | Q12815 | |
| VILPLISRLSDPDWI | 246 | Q92543 | |
| SALWLTPEQTCLLQP | 756 | Q96JE7 | |
| INTPLWPCDRLDVLN | 1441 | Q8N9V7 | |
| TPLPLTDSWVRACAN | 11 | Q8N398 | |
| LPLEEIWPLCDFITV | 191 | O43175 | |
| WTLGCLSPESQFRIP | 26 | P0DMS9 | |
| QPLPTAEITRLAVWA | 176 | Q9ULD5 | |
| LLPRSLWPACQESVT | 41 | P0C6A0 | |
| CREPLNVVPWNLTLF | 146 | P48230 | |
| ILPTEIETWVREHCP | 81 | Q6P9G9 | |
| TQASQICLLLPESPW | 56 | Q96M85 | |
| RDCLILTWAPPSDTR | 386 | Q5VTT5 |